Pharma Industary

Roots Analysis has done a detailed study on Next Generation Sequencing Kits Market, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 200+ page report, which features 70+ figures and 120+ tables, please visit this https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market/free-insights.html

Key Market Insights

 Presently, more than 280 NGS library preparation kits are being offered by close to 60 players; these kits are compatible with a variety of input samples, including purified RNA / DNA and cells

 Leveraging their expertise, stakeholders within this domain are offering a myriad of NGS kits for preparing DNA and RNA libraries; majority of such kits require less than 5 ng of input samples

 The current market landscape is fragmented, featuring both new entrants and established players; the US is currently considered to be a hub of innovation related to NGS library preparation kits

 In pursuit of gaining a competitive edge, NGS library preparation kit providers are presently focusing on expansion of their existing capabilities and augmenting their respective product portfolios

 Around 3,250 patents related to NGS library preparation kits have recently been filed / granted, indicating the heightened pace of innovation in this domain

 Case Study: Around 70 industry players claim to offer elaborate portfolios of NGS based services, leveraging a variety of second and third generation sequencing technologies

 The market is anticipated to grow at a CAGR of 18%, till 2035, and the projected opportunity is likely to be distributed across different type of nucleotide sequenced, end user and key geographical regions

For more information, please visit https://www.rootsanalysis.com/reports/next-generation-sequencing-kits-market.html

Table of Contents

1. PREFACE

1.1. Scope of the Report

1.2. Research Methodology

1.3. Key Questions Answered

1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Overview of Genome Sequencing

3.3. Types of Genome Sequencing

3.3.1. Next Generation Sequencing

3.3.1.1. Applications of Next Generation Sequencing

3.3.1.1.1. Cancer and Affiliated Biomarker Research

3.3.1.1.2. Diagnostics

3.3.1.1.3. Personalized / Precision Medicine

3.3.1.1.4. Forensics

3.3.1.2. Steps Involved in Next Generation Sequencing

3.3.1.2.1. Library Preparation

3.3.1.2.2. Amplification

3.3.1.2.3. Sequencing

3.3.1.2.4. Bioinformatics Analysis and Data Interpretation

3.3.1.3. Components of Next Generation Sequencing Kits

3.4. Future Perspectives

4. MARKET LANDSCAPE

4.1. Chapter Overview

4.2. Next Generation Sequencing Kits: Overall Market Landscape

4.2.1. Analysis by Type of Nucleotide Sequenced

4.2.2. Analysis by Kit Components

4.2.3. Analysis by Quantity of Sample Required

4.2.4. Analysis by Turnaround Time

4.2.5. Analysis by Storage Temperature

4.2.6. Analysis by Type of Sample Used

4.2.7. Analysis by Kit Shelf Life

4.2.8. Analysis by Type of Sequencing

4.2.9. Analysis by Type of Sequencing Platform Used

4.3. Next Generation Sequencing Kits: List of Providers

4.3.1. Analysis by Year of Establishment

4.3.2. Analysis by Company Size

4.3.3. Analysis by Location of Headquarters

4.3.4. Leading Players: Analysis by Number of Products

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview

5.2. Assumptions and Methodology

5.3. Product Competitiveness Analysis: Competitive Landscape

6. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN NORTH

AMERICA

6.1. Chapter Overview

6.2. Agilent Technologies

6.2.1. Company Overview

6.2.2. Financial Information

6.2.3. NGS Kit Portfolio

6.2.4. Recent Developments and Future Outlook

6.3. BioDynami

6.3.1. Company Overview

6.3.2. NGS Kit Portfolio

6.3.3. Recent Developments and Future Outlook

6.4. Creative Biogene

6.4.1. Company Overview

6.4.2. NGS Kit Portfolio

6.4.3. Recent Developments and Future Outlook

6.5. New England Biolabs

6.5.1. Company Overview

6.5.2. NGS Kit Portfolio

6.5.3. Recent Developments and Future Outlook

6.6. PerkinElmer

6.6.1. Company Overview

6.6.2. Financial Information

6.6.3. NGS Kit Portfolio

6.6.4. Recent Developments and Future Outlook

6.7. Thermo Fisher Scientific

6.7.1. Company Overview

6.7.2. Financial Information

6.7.3. NGS Kit Portfolio

6.7.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN EUROPE

7.1. Chapter Overview

7.2. Abcam

7.2.1 Company Overview

7.2.2. Financial Information

7.2.3. NGS Kit Portfolio

7.2.4. Recent Developments and Future Outlook

7.3. Devyser

7.3.1 Company Overview

7.3.2. NGS Kit Portfolio

7.3.3. Recent Developments and Future Outlook

7.4. Diagenode

7.4.1 Company Overview

7.4.2. NGS Kit Portfolio

7.4.3. Recent Developments and Future Outlook

7.5. Lexogen

7.5.1 Company Overview

7.5.2. NGS Kit Portfolio

7.5.3. Recent Developments and Future Outlook

7.6. Roche

7.6.1 Company Overview

7.6.2. Financial Information

7.6.3. NGS Kit Portfolio

7.6.4. Recent Developments and Future Outlook

7.7. Tecan

7.7.1 Company Overview

7.7.2. Financial Information

7.7.3. NGS Kit Portfolio

7.7.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN ASIA

PACIFIC

8.1. Chapter Overview

8.2. Enzynomics

8.2.1. Company Overview

8.2.2. NGS Kit Portfolio

8.2.3. Recent Developments and Future Outlook

8.3. MGI

8.3.1. Company Overview

8.3.2. NGS Kit Portfolio

8.3.3. Recent Developments and Future Outlook

8.4. Takara Bio

8.4.1. Company Overview

8.4.2. Financial Information

8.4.3. NGS Kit Portfolio

8.4.4. Recent Developments and Future Outlook

8.5. TIANGEN Biotech

8.5.1. Company Overview

8.5.2. NGS Kit Portfolio

8.5.3. Recent Developments and Future Outlook

8.6. TransGen Biotech

8.6.1. Company Overview

8.6.2. NGS Kit Portfolio

8.6.3. Recent Developments and Future Outlook

8.7. Vazyme

8.7.1. Company Overview

8.7.2. NGS Kit Portfolio

8.7.3. Recent Developments and Future Outlook

9. PATENT ANALYSIS

9.1. Chapter Overview

9.2. Scope and Methodology

9.3. Next Generation Sequencing Kits: Patent Analysis

9.3.1 Analysis by Application Year

9.3.2. Analysis by Geography

9.3.3. Analysis by CPC Symbols

9.3.4. Emerging Focus Areas

9.3.5. Analysis by Type of Applicant

9.3.6. Leading Players: Analysis by Number of Patents

9.4. Next Generation Sequencing Kits: Patent Benchmarking

9.4.1. Analysis by Patent Characteristics

9.5. Next Generation Sequencing Kits: Patent Valuation

9.6. Leading Patents: Analysis by Number of Citations

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview

10.2. Forecast Methodology and Key Assumptions

10.3. Global Next Generation Sequencing Kits Market, 2021-2035

10.3.1. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of Nucleotide

Sequenced

10.3.1.1. Next Generation Sequencing Kits Market for DNA, 2021-2035

10.3.1.2. Next Generation Sequencing Kits Market for RNA, 2021-2035

10.3.2. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of End User

10.3.2.1. Next Generation Sequencing Kits Market for Hospitals and Clinics, 2021-2035

10.3.2.2. Next Generation Sequencing Kits Market for Pharmaceutical and Biotechnology Companies,

2021-2035

10.3.2.3. Next Generation Sequencing Kits Market for Academic and Research Institutes, 2021-2035

10.3.2.4. Next Generation Sequencing Kits Market for Others, 2021-2035

10.3.3. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Geography

10.3.3.1. Next Generation Sequencing Kits Market in North America, 2021-2035

10.3.3.2. Next Generation Sequencing Kits Market in Europe, 2021-2035

10.3.3.3. Next Generation Sequencing Kits Market in Asia Pacific, 2021-2035

10.3.3.4. Next Generation Sequencing Kits Market in Middle East and North Africa, 2021-2035

10.3.3.5. Next Generation Sequencing Kits Market in Latin America, 2021-2035

10.3.3.6. Next Generation Sequencing Kits Market in Rest of the World, 2021-2035

11. CASE STUDY: NEXT GENERATION SEQUENCING TECHNOLOGIES AND SERVICE

PROVIDERS

11.1. Chapter Overview

11.2. Historical Evolution of Genome Sequencing

11.2.1. First Generation DNA Sequencers

11.2.2. Second Generation HT-NGS Platforms

11.2.3. Third Generation HT-NGS Platforms

11.2.3.1. Heliscope Single Molecule Sequencer

11.2.3.2. Single Molecule Real Time Sequencer

11.2.3.3. Single Molecule Real Time (RNAP) Sequencer

11.2.3.4. Nanopore DNA Sequencer

11.2.3.5. Multiplex Polony Technology

11.2.3.6. The Ion Torrent Sequencing Technology

11.2.4. Comparison of First, Second and Third Generation technologies

11.3. Next Generation Sequencing Technologies

11.3.1. Analysis by Type of Application

11.4. Next Generation Sequencing Service Providers

11.4.1. Next Generation Sequencing Service Providers: Industry Players

11.4.2. Analysis by Year of Establishment

11.4.3. Analysis by Company Size

11.4.4. Analysis by Location of Headquarters

11.4.5. Analysis by Type of Service Offered

11.5. Next Generation Sequencing Service Providers: Non-Industry Players

11.5.1. Analysis by Year of Establishment

11.5.2. Analysis by Location of Headquarters

11.5.3. Analysis by Type of Service Offered

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

13.1. Chapter Overview

13.2. Tecan

13.2.1. Company Snapshot

13.2.2. Interview Transcript: Len Goren, General Manager

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Contact Details

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com